Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multicenter, Open-Label Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of Gammaplex® in Primary Immunodeficiency Diseases

NCT00278954 is registered in ClinicalTrials.gov with Bio Products Laboratory as lead sponsor.

NCT NCT00278954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00278954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multicenter, Open-Label Study To Evaluate The Efficacy, Safety, and Pharmacokinetics of Gammaplex® in Primary Immunodeficiency Diseases
Lead sponsor
Bio Products Laboratory
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
November 30, 2007
Enrollment
50 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

common variable hypogammaglobulinemia, hypogammaglobulinemia, immunodeficiency with hyper-igm, primary immunodeficiency, wiskott-aldrich syndrome, x-linked hypogammaglobulinemia